Eddie Hickman
Stock Analyst at Guggenheim
(0.92)
# 2022
Out of 5,329 analysts
17
Total ratings
33.33%
Success rate
20.07%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PMN ProMIS Neurosciences | Reiterates: Buy | 6 6 | 0.65 | 823.08% | 2 | Apr 1, 2025 | |
ZVRA Zevra Therapeutics | Maintains: Strong Buy | 20 22 | 7.68 | 186.46% | 1 | Mar 13, 2025 | |
GHRS GH Research | Initiates Coverage On: Buy | 32 | 10.76 | 197.4% | 1 | Mar 13, 2025 | |
CYBN Cybin | Initiates Coverage On: Buy | 35 | 6.56 | 433.54% | 1 | Mar 13, 2025 | |
TARS Tarsus Pharmaceutica... | Maintains: Strong Buy | 75 78 | 50.4 | 54.76% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 1.58 | 659.49% | 3 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | May 1, 2023 |